Schistosoma mansoni tetraspanin-2 (Sm-TSP-2) (Sm-TSP-2)

Schistosoma mansoni tetraspanin-2 (Sm-TSP-2) is a 24-kDa integral membrane protein that is highly expressed on the surface tegument of the adult and schistosomula stages of the parasite (Tran et al., 2006). It belongs to the tetraspanin superfamily, which is characterized by four transmembrane domains and two extracellular loops, with the large extracellular loop (LEL) being the primary site for host-parasite interactions and immune recognition (Hotez et al., 2010). Sm-TSP-2 plays a crucial role in the structural integrity and biogenesis of the tegument, a dynamic syncytial layer that protects the worm from the host's immune system and physiological environment (Da'dara et al., 2012). Experimental silencing of the Sm-TSP-2 gene via RNA interference leads to significant tegumental defects and increased parasite mortality, highlighting its essentiality for survival (Tran et al., 2006). Because individuals naturally resistant to schistosomiasis produce high levels of IgG1 and IgG3 antibodies against the Sm-TSP-2 LEL, it has been prioritized as a leading vaccine candidate (Hotez et al., 2010). The recombinant Sm-TSP-2 LEL protein, formulated with Alhydrogel, is currently undergoing clinical trials to evaluate its safety and ability to induce protective immunity in humans (NCT02337855). Vaccination aims to generate neutralizing antibodies that disrupt the tegumental barrier, thereby reducing worm burden and egg-induced pathology in the host (Pearson et al., 2012). This target represents a significant advancement in the development of a transmission-blocking vaccine for one of the world's most prevalent neglected tropical diseases.

Other names

Sm-TSP-2Tetraspanin-2Sm-TSP2Sm24

Induction of protective IgG antibodies that target the large extracellular loop (LEL) of the tetraspanin protein, disrupting the integrity of the parasite's tegument and preventing its survival and development within the host (Tran et al., 2006).